Endpoints News ١٢ مارس ٢٠٢٦ Novo Holdings’ assets fell by a third in 2025 as Novo Nordisk’s value sank
Endpoints News ٢٧ فبراير ٢٠٢٦ Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the future
Endpoints News ٢٤ فبراير ٢٠٢٦ Novo Nordisk’s triple-G is competitive with Lilly in obesity, but likely to be second to market
Endpoints News ٢٣ فبراير ٢٠٢٦ Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial
Endpoints News ٩ فبراير ٢٠٢٦ Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking 'hundreds of millions' in damages
Endpoints News ٤ فبراير ٢٠٢٦ Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
Endpoints News ١٦ يناير ٢٠٢٦ Novo Nordisk, BioMarin make AI moves; Bristol Myers welcomes neurology exec from Eisai
Endpoints News ١٥ يناير ٢٠٢٦ A compounding pharmacy hits back at Eli Lilly, Novo Nordisk with antitrust lawsuit
Endpoints News ١٥ يناير ٢٠٢٦ FDA to meet Novo Nordisk on troubled site; AbbVie buys drug-device factory
Endpoints News ١٥ يناير ٢٠٢٦ Novo Nordisk Foundation to inject $850M+ into BioInnovation Institute through 2035
Endpoints News ١٢ يناير ٢٠٢٦ #JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom